γ-secretase is a transmembrane protease responsible for the eventual cleavage of amyloid precursor protein (APP) to generate Aβ (Figure 1), thus it is considered a principal therapeutic target in Alzheimer's disease [45, 46]. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.